More people are using GLP-1’s the way they do Botox: They decide how much to take and when — and hope for the best.

Don’t want to do intense cardio to lose weight? You don’t have to.

Hormone therapy for menopause is safer than doctors had previously thought, new research says. It may also bring unexpected ...

A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce ...

Year after year, Mary Bucklew strategized with a nurse practitioner about losing weight. "We tried exercise," like walking 35 minutes a day, she recalled. "And 39,000 different diets." But 5 pounds ...

The GLP-1/GIP dual-receptor agonist tirzepatide led to at least 15% loss of total body fat in premenopausal, perimenopausal, and postmenopausal women, but postmenopausal women taking menopausal ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. A new study found that weight loss in older ...

Among older adults with overweight or obesity undergoing a weight-loss intervention, those with a higher protein intake had increased hip bone strength in the short term but no significant change in ...

LONDON, Dec 9 (Reuters) - Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly (LLY.N), opens new tab and Novo Nordisk (NOVOb.CO), opens new ...

Year after year, Mary Bucklew strategized with a nurse practitioner about losing weight. “We tried exercise,” like walking 35 minutes a day, she recalled. “And 39,000 different diets.” But 5 pounds ...